Lv3
358 积分 2024-01-04 加入
Functional genomic landscape of acute myeloid leukaemia
4天前
已关闭
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors
5天前
已完结
How KRAS Mutations Impair Intrinsic GTP Hydrolysis: Experimental and Computational Investigations
16天前
已完结
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
19天前
已完结
Final Results of the Chrysalis Trial: A First-in-Human Phase 1/2 Dose-Escalation, Dose-Expansion Study of Gilteritinib (ASP2215) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
21天前
已完结
A Meta‐Analysis on Gilteritinib Using Real‐World and Randomized Trial Data in Patients With FLT3‐Mutated Refractory/Relapsed Acute Myeloid Leukemia
22天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
26天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
26天前
已完结
ERK signalling: a master regulator of cell behaviour, life and fate
2个月前
已完结
GSK3 inhibitors: development and therapeutic potential
2个月前
已完结
皖公网安备34019202002308
